Eversense
Manufacturing · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
29 Commercial St, Dundee, Angus, DD1 3DG...Website
www.eversensediabetes.comRevenue
$27.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Eversense
Eversense Diabetes offers the Eversense E3 Continuous Glucose Monitoring (CGM) System, designed for individuals with diabetes aged 18 and older. This innovative system features a long-term sensor that provides continuous glucose readings for up to six months, eliminating the need for frequent fingersticks. The sensor is inserted by a healthcare provider, and the accompanying smart transmitter sends data to a mobile app for real-time monitoring. Eversense aims to enhance diabetes management through accurate, convenient, and discreet glucose monitoring solutions.Explore more
Eversense Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Eversense your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Eversense had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Eversense has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Eversense
Funding: Get notified immidiatlly once Eversense has new funding data
Check out if Eversense is spiking on competitors!
Earning: See what the market has to say on Eversense recently announced quarterly report
Eversense, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Eversense launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Eversense as Masked Content
Find 2 more new buyers
Compare Similar Companies to Eversense
Compare insights from companies similar to Eversense, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Eversense is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Eversense is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Eversense.
Eversense Tech Stack
A closer look at the technologies used by Eversense
Eversense News & Media
Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems
Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performanceSenseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026
GERMANTOWN, Md., June 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today highlights two key company events during the 86th Scientific Sessions of the American Diabetes Association (ADA), taking place June 5-8 in New Orleans, Louisiana. Senseonics will be hosting an analyst event to diSenseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System
The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a phased roll outFirst Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear
New data shows positive real-world impact of the world’s first and only one-year CGM, with a full year of strong patient adherence, glucometrics and hypoglycemic outcomes
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eversense
Sign Up For FreeTo access detailed company insights
Eversense Diabetes offers the Eversense E3 Continuous Glucose Monitoring (CGM) System, designed for individuals with diabetes aged 18 and older. This innovative system features a long-term sensor that provides continuous glucose readings for up to six months, eliminating the need for frequent fingersticks. The sensor is inserted by a healthcare pro... Read More
